Jackson S, Graubard B, Gabbi C, Koshiol J
Sci Rep. 2024; 14(1):191.
PMID: 38168135
PMC: 10761940.
DOI: 10.1038/s41598-023-50509-2.
Sun H, Warren J, Yip J, Ji Y, Hao S, Han W
Biomolecules. 2022; 12(4).
PMID: 35454138
PMC: 9026518.
DOI: 10.3390/biom12040550.
Wang S, Wang Y, Xu J, Chen Y
Medicine (Baltimore). 2017; 96(14):e6556.
PMID: 28383429
PMC: 5411213.
DOI: 10.1097/MD.0000000000006556.
Gialeraki A, Valsami S, Pittaras T, Panayiotakopoulos G, Politou M
Clin Appl Thromb Hemost. 2017; 24(2):217-225.
PMID: 28049361
PMC: 6714678.
DOI: 10.1177/1076029616683802.
Le Roux Y, Borg M, Sibille M, Thebault J, Renoux A, Douin M
Clin Drug Investig. 2016; 10(3):172-8.
PMID: 27519201
DOI: 10.2165/00044011-199510030-00006.
Statin treatment and risk of recurrent venous thromboembolism: a nationwide cohort study.
Nguyen C, Andersson C, Jensen T, Gjesing A, Olsen A, Hansen C
BMJ Open. 2013; 3(11):e003135.
PMID: 24202053
PMC: 3822311.
DOI: 10.1136/bmjopen-2013-003135.
New insights into the molecular mechanisms underlying effects of estrogen on cholesterol gallstone formation.
Wang H, Liu M, Clegg D, Portincasa P, Wang D
Biochim Biophys Acta. 2009; 1791(11):1037-47.
PMID: 19589396
PMC: 2756670.
DOI: 10.1016/j.bbalip.2009.06.006.
Learning how to control biases in studies to identify adverse effects of drugs: a brief personal history.
Jick H
J R Soc Med. 2009; 102(4):160-4.
PMID: 19349509
PMC: 2666051.
DOI: 10.1258/jrsm.2009.09k002.
Alterations in gallbladder emptying and bile retention in the absence of changes in bile lithogenicity in postmenopausal women on hormone replacement therapy.
Dhiman R, Sarkar P, Sharma A, Vasishta K, Kohli K, Gupta S
Dig Dis Sci. 2004; 49(7-8):1335-41.
PMID: 15387365
DOI: 10.1023/b:ddas.0000037831.77490.06.
The adverse effects of hormone replacement therapy.
Tavani A, La Vecchia C
Drugs Aging. 1999; 14(5):347-57.
PMID: 10408735
DOI: 10.2165/00002512-199914050-00003.
Assessment of the risk for venous thromboembolism among users of hormone replacement therapy.
Oger E, Scarabin P
Drugs Aging. 1999; 14(1):55-61.
PMID: 10069408
DOI: 10.2165/00002512-199914010-00004.
Recent epidemiological studies of the association between hormone replacement therapy and venous thromboembolism. A review.
Castellsague J, Perez Gutthann S, Garcia Rodriguez L
Drug Saf. 1998; 18(2):117-23.
PMID: 9512918
DOI: 10.2165/00002018-199818020-00003.
Hormone replacement therapy and breast cancer. A review of current knowledge.
Bergkvist L, Persson I
Drug Saf. 1996; 15(5):360-70.
PMID: 8941497
DOI: 10.2165/00002018-199615050-00006.
Effect of castration and hormonal supplementation on cholesterol cholelithiasis in the male hamster.
Ohshima A, Cohen B, Ayyad N, MOSBACH E
Lipids. 1996; 31(9):945-8.
PMID: 8882973
DOI: 10.1007/BF02522687.
Effect of a synthetic androgen on biliary lipid secretion in the female hamster.
Ohshima A, Cohen B, Ayyad N, MOSBACH E
Lipids. 1996; 31(8):879-86.
PMID: 8869891
DOI: 10.1007/BF02522984.
Hormone replacement therapy in the aged. A state of the art review.
Jacobs S, Hillard T
Drugs Aging. 1996; 8(3):193-213.
PMID: 8720745
DOI: 10.2165/00002512-199608030-00005.
Non-contraceptive exogenous estrogens and risk of breast cancer: a review.
Thomas D
Breast Cancer Res Treat. 1982; 2(3):203-11.
PMID: 6295528
DOI: 10.1007/BF01806932.
Comparison of biliary lipid secretion in non-obese cholesterol gallstone patients with normal, young, male volunteers.
Leiss O, von Bergmann K
Klin Wochenschr. 1985; 63(22):1163-9.
PMID: 4079281
DOI: 10.1007/BF01740592.
Menopausal estrogen use and the risk of breast cancer.
McDonald J, Weiss N, Daling J, Francis A, Polissar L
Breast Cancer Res Treat. 1986; 7(3):193-9.
PMID: 3779117
DOI: 10.1007/BF01806250.
Splenic and renal infarction in systemic lupus erythematosus: association with anti-cardiolipin antibodies.
Arnold M, Schrieber L
Clin Rheumatol. 1988; 7(3):406-10.
PMID: 3229088
DOI: 10.1007/BF02239202.
